SavedAdd your journal

Journals / Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi / 2022 / Cilt: 9 - Sayı: 2

The Change in Expression Levels of RYBP and MDM2 Genes in Colorectal Cancer

Kolorektal Kanserde RYBP ve MDM2 Genlerinin Ekspresyon Düzeylerindeki Değişimi

Türkan GÜRER
Alper AYTEKİN
Amina FARHAN
Pages
319–324
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: In this study results showed that the expression levels of both RYBP and MDM2 were decreased in tumor tissues compared to normal tissues with colorectal cancer patients, but these decreases were not statistically significant (p=0.673 and p=0.721, respectively).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Colorectal cancer, frequently seen among gastrointestinal cancers, is one of the major causes in mortality and morbidity worldwide.
📊
Key Findings & Data:In this study, we aimed to investigate the expression levels of RYBP and MDM2 genes in colorectal cancer.
💡
Conclusion & Impact:Results: In this study results showed that the expression levels of both RYBP and MDM2 were decreased in tumor tissues compared to normal tissues with colorectal cancer patients, but these decreases were not statistically significant (p=0.673 and p=0.721, respectively).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Kolorektal kanser · Gen ekspresyonu · RYBP

Abstract

Objective: Colorectal cancer, frequently seen among gastrointestinal cancers, is one of the major causes in mortality and morbidity worldwide. In this study, we aimed to investigate the expression levels of RYBP and MDM2 genes in colorectal cancer. We further examined the possible correlation between RYBP and MDM2 expressions in colorectal cancer and the relationship between the expression of these genes and the clinicopathological features of patients with colorectal cancer. Materials and Methods: In this study, fresh tumor colon/rectum tissues and the adjacent healthy tissues collected from 43 patients with colorectal cancer during a surgical operation. RYBP and MDM2 mRNA expressions were examined using Real-Time PCR. Results: In this study results showed that the expression levels of both RYBP and MDM2 were decreased in tumor tissues compared to normal tissues with colorectal cancer patients, but these decreases were not statistically significant (p=0.673 and p=0.721, respectively). Moreover, while there was no correlation between RYBP and MDM2 mRNA expressions in colorectal cancer, no statistically significant relationship was found between the expressions of these genes and clinicopathological data (p>0.05). Conclusion: Consequently, it can be said that RYBP and MDM2 expressions are not related to colorectal cancer, however, future studies with larger sample groups are needed to validate the results obtained from this study.

Özet

Giriş ve Amaç: Gastrointestinal kanserler arasında sıklıkla görülen kolorektal kanser, dünya genelinde mortalite ve morbiditenin en önemli nedenlerinden biridir. Bu çalışmada kolorektal kanserde RYBP ve MDM2 genlerinin ekspresyon düzeylerini araştırmayı amaçladık. Ayrıca kolorektal kanserde RYBP ve MDM2 ekspresyonları arasındaki olası korelasyonu ve bu genlerin ekspresyonu ile kolorektal kanserli hastaların klinikopatolojik özellikleri arasındaki ilişkiyi inceledik. Gereç ve Yöntemler: Bu çalışmada, cerrahi operasyon sonucunda 43 kolorektal kanserli hastanın tümörlü kolon/rektum dokuları ve komşu sağlıklı dokuları toplandı. RYBP ve MDM2 mRNA ekspresyonları Real-Time PCR kullanılarak incelendi. Bulgular: Çalışmanın sonucunda tümörlü dokularda normal dokulara kıyasla hem RYBP hem de MDM2 ekspresyonlarında azalış görüldü fakat bu azalış istatistiksel açıdan anlamlı değildi (sırasıyla p=0.673 ve p=0.721). Ayrıca kolorektal kanserde RYBP ve MDM2 mRNA ekspresyonları arasında korelasyon bulunmazken, bu genlerin ekspresyonları ile klinikopatolojik veriler arasında istatistiksel olarak anlamlı bir ilişki saptanmadı (p>0.05). Sonuç: Sonuç olarak, RYBP ve MDM2 ekspresyonlarının kolorektal kanser ile ilişkili olmadığı söylenebilir, ancak bu çalışmadan elde edilen sonuçları doğrulamak için daha büyük örneklem grupları ile yapılacak çalışmalara ihtiyaç vardır.

🔖

Cite This Article

GÜRER, T., AYTEKİN, A., FARHAN, A. (2022). The Change in Expression Levels of RYBP and MDM2 Genes in Colorectal Cancer. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, Cilt: 9 - Sayı: 2, 319–324. https://ajindex.com/articles/472668

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Keum, N, Giovannucci, E, Global burden of colorectal cancer:emerging trends, risk factors and prevention strategies, Nature Reviews Gastroenterology & Hepatology, 2019,16, 713-32
  2. Rawla, P, Sunkara, T, Barsouk, A, Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors, Gastroenterology Review, 2019, 14(2), 89-103
  3. Dekker, E, Tanis, P.J, Vleugels, J.L.A, Kasi, P.M, Wallace, M.B, Colorectal cancer, Lancet, 2019, 394, 1467-80
  4. Martinez, A.M, Cavalli, G, The role of polycomb group proteins in cell cycle regulation during development, Cell Cycle, 2006, 5(1), 1189-97
  5. Wang, W, Cheng, J, Qin, J.J, Voruganti, S, Nag, S, Fan, Gao, Q, Zhang, R, RYBP expression is associated with better survival of patients with hepatocellular carcinoma (HCC) and responsiveness to chemotherapy of HCC cells in vitro and in vivo, Oncotarget, 2014, 5, 11604-19
  6. Zhan, S, Wang, T, Ge, W, Li, J. Multiple roles of Ring 1 and YY1 binding protein in physiology and disease, Journal of Cellular and Molecular Medicine, 2018, 22(4), 2046-54
  7. Lando, M, Wilting, S.M, Snipstad, K, Clancy, T, Bierkens, M, Aarnes, E.K, Holden, M, Stokke, T, Sundfør, K, Holm, R, Kristensen, G.B, Steenbergen, R.D, Lyng, H, Identification of eight candidate target genes of the recurrent 3p12-p14 loss in cervical cancer by integrative genomic profiling, The Journal of Pathology, 2013, 230(1), 59-69
  8. Krohn, A, Seidel, A, Burkhardt, L, Bachmann, F, Mader, M, Grupp, K, Eichenauer, T, Becker, A, Adam, M, Graefen, M, Huland, H, Kurtz, S, Steurer, S, Tsourlakis, M.C, Minner, S, Michl, U, Schlomm, T, Sauter, G, Simon, R, Sirma, H, Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion‐positive prostate cancers, The Journal of Pathology, 2013, 231(1), 130-41
  9. Zhu, X, Yan, M, Luo, W, Liu, W, Ren, Y, Bei, C, Tang, G, Chen, R, Tan, S, Expression and clinical significance of PcG associated protein RYBP in hepatocellular carcinoma, Oncology Letters, 2017, 13, 141-50
  10. Ke, Y, Guo, W, Huang, S, Li, Y, Guo, Y, Liu, X, Jin, Y, Ma, H, RYBP inhibits esophageal squamous cell carcinoma proliferation through downregulating CDC6 and CDC45 in G1-S phase transition process, Life Sciences, 2020, 250, 117578
  11. Zhao, Y, Yu, H, Hu, W, The regulation of MDM2 oncogene and its impact on human cancers, Acta Biochimica et Biophysica Sinica, 2014, 46, 180-9
  12. Liu, L, Yang, L, Chang, H, Chen, Y.N, Zhang, F, Feng, S, Peng, J,